Article Text

Download PDFPDF
Intraretinal pigmented cells in retinal degenerative disease
  1. Marina Yasvoina1,
  2. Qian Yang1,
  3. Sasha M Woods1,
  4. Tjebo Heeren2,
  5. Grant M. Comer3,
  6. Catherine A. Egan2,
  7. Marcus Fruttiger1
  1. 1UCL Institute of Ophthalmology, University College London, London, UK
  2. 2Moorfields Eye Hospital, NHS Foundation Trust, London, UK
  3. 3W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA
  1. Correspondence to Dr Marcus Fruttiger, Institute of Ophthalmology, UCL, London, London, UK; m.fruttiger{at}ucl.ac.uk

Abstract

Purpose Invasion of pigmented cells into the retina occurs in retinal degenerative diseases, such as macular telangiectasia type 2 (MacTel) and retinitis pigmentosa (RP). These intraretinal pigmented cells may be derived from the retinal pigment epithelium (RPE), but differences and similarities between intraretinal pigmented cells and RPE have so far not been well characterised.

Clinicopathologic case report.

Method Here, we compared intraretinal pigment cells with RPE cells by immunohistochemistry. Immunohistological stains for classic RPE markers (RPE65, CRALBP and KRT18) and blood vessel markers (lectin and collagen 4) were done on sections from postmortem eye tissue from two MacTel donors, an RP donor and a control donor.

Main outcome measures Presence of specific immunohistochemistry markers on intraretinal pigmented and RPE cells.

Results We found that intraretinal pigmented cells did not express RPE65 and CRALBP, with a small subset expressing them weakly. However, they all expressed KRT18, which was also present in normal RPE cells. Interestingly, we also found clusters of KRT18-positive cells in the retina that were not pigmented.

Conclusions Our findings suggest that RPE cells invading the retina dedifferentiate (losing classic RPE markers) and can be pigmented or unpigmented. Therefore, the number of RPE cells invading the retina in retinal degenerative disease may be underappreciated by funduscopy.

  • retina
  • pathology
  • degeneration

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text

Footnotes

  • Twitter @mfruttiger

  • Contributors MY and MF designed the study, MY, QY, SMW contributed to data collection, data analysis and figure making, and all authors contributed to the interpretation of data and the writing and revision of the manuscript. MF is guarantor.

  • Funding This work was supported by the Lowy Medical Research Institute (LMRI), La Jolla, USA; TH received financial support from the LMRI. CE and MF are partially funded by the National Institute of health research (NIHR) Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The sponsor or funding organisations had no role in the design or conduct of this research.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.